一、項目單位：呂梁盛達生化有限公司。

　　二、項目概況：

　　       1、建設規模及內容：年產20噸硫酸軟骨素、10噸溶菌酶。

　　       2、市場分析：用于生產生化原料藥的生物原料極為豐富，但大部分在今后相當長的時期內還屬于資源依賴性產品，雖然有的品種可以用基因重組等現代生物技術生產，但尚未達到商業化水平。而我們利用生物資源生產的生化藥物，有效地保障了醫藥的臨床需要，而且成為市場上的搶手貨。硫酸軟骨素已成為出口量最大的生化醫藥產品，主要銷往美、歐等國。溶菌酶由于具有專一性分解細胞壁的能力，用途十分廣泛，目前國內生產的該產品只能滿足市場需求的三分之一，產品主銷大連、上海。

　　       3、建設條件：該項目屬國家鼓勵投資項目，已批準進入離石輕工科技園區，建設條件及公用設施配套良好。硫酸軟骨素是從豬、牛、羊等動物的軟骨組織中，經堿提取蛋白質后制成的一種酸性粘多糖類藥物。溶菌酶是從雞蛋清中提取的一種酶制劑。上述產品的原料可就近解決。

　　       4、投資估算及資金籌措：總投資5000萬元，其中自籌1000萬元，擬引進資金4000萬元。

　　       5、項目建設期：一年。

　　       6、效益分析：

　　       年可實現銷售收入4160萬元，實現利潤1340萬元，上交稅金400萬元。項目建成后，可新增就業人數200余人，同時可帶動周邊養殖業的快速發展。

　　       7、合作方式：合資、合作均可。

　　三、聯系方式：

　　    聯系地址：離石區發展計劃局

　　       聯 系 人：郭春元

　　       聯系電話：0358-8222524

　　

　　

　　

　　Sulphuric Acid CartilageElement &&. Bacteriolytic Enzyme Production

　?。桑校颍铮辏澹悖?/span> Ｕｎｉｔ

　　       Luliang  Shengda Biochemistry Co., Ltd

　?。桑桑拢颍椋澹?/span> Ｉｎｔｒｏｄｕｃｔｉｏｎ ｔｏ ｔｈｅ Ｐｒｏｊｅｃｔ

　　       1.Construction Scale and Its Content:  20t/y sulphuric acid cartilage element, 10t/y bacteriolytic enzyme

　　       2.Market Analysis:  The biological resources for producing biochemical materials are very rich, but a great deal of it belongs to resource-relying products in a long run. Some kinds of resources can be produced by the way of gene recombination, but it can not meet the need of the market. The biochemical medicine produced in the company is to make use of the local biological resources and meet the clerical need of hospitals. It is in great need in market. Sulphuric aid cartilage element the biochemical medicinal product which is the largest exported product to the U.S. and European countries. Bacteriolytic enzyme can be used to decompose cell wall and has a wide application. The amount presently produced in the country can only meet the one third of market demand and mainly sold to Dalian and Shanghai. 

　　       3.Construction Condition: The project has been listed in the State-supporting items and approved to enter Lishi Light Industry Sci-tech Park with a good facilities and infrastructure. Sulphuric acid cartilage element is an acid carbonhydrate medicine extracted from cartilage tissues of pig, cow and sheep. Bacteriolytic enzyme is an enzyme preparation extracted for egg whites. The raw material for production can be obtained locally.

　　       4.Total Investment: The total investment will be 50 million yuan of which 10 million yuan will be self funded and 40 million yuan introduced.

　　       5.Construction period: 1 year

　　       6.Benefit Analysis: After its completion, the annual sales income will be 41.6 million yuan, profit 13.4 million yuan, and tax 4 million yuan. It can provide 200 job opportunities.

　　       7.Cooperation Form

　　       Joint Venture, Cooperation

　?。桑桑桑茫铮睿簦幔悖?/span> Ｆｏｒｍ

　　       Add:Lishi Development Planning Bureau

　　       Liaison:Guo Chunyuan

　　       Tele:0358-8222524